{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001174940","name":"ORAGENICS INC","summary":"Oragenics Inc. is a development-stage biopharmaceutical company focused on nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. Its lead product, ONP-002, is a fully synthetic neurosteroid administered via a novel intranasal breath-powered device, designed to treat mild traumatic brain injury (mTBI/concussion) by reducing swelling, oxidative stress, and inflammation while restoring blood flow through gene amplification. ONP-002 has completed Phase 1 clinical trials in Australia and is targeting Phase 2a initiation in Q1 2026.","people":[],"products":[{"name":"ONP-002","type":"hardware","description":"Fully synthetic neurosteroid powder delivered via breath-powered intranasal device for treatment of mild traumatic brain injury and concussion."},{"name":"Breath-Powered Nasal Device","type":"hardware","description":"Novel lightweight intranasal delivery device that uses breath propulsion to deliver drug powder to the nasal cavity and brain."}],"partnerships":[{"partner_name":"Avance Clinical Pty Ltd","partnership_type":"development","description":"Contract Research Organization supporting Phase 1 clinical trial conducted in Melbourne, Australia.","start_date":null},{"partner_name":"Nucleus Network Pty Ltd","partnership_type":"development","description":"Contract Research Organization supporting Phase 1 clinical trial conducted in Melbourne, Australia.","start_date":null},{"partner_name":"Charles River, Inc.","partnership_type":"development","description":"Planned GLP cardiopulmonary safety pharmacology study to be conducted prior to IND submission.","start_date":null}],"affiliations":[],"origin":{"leaf":"46a9ec655ec4e01309deaf72d8ae8e38d6f8f0609b9f2b89f59fccef942c48d9","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"10e440f413ddf0060d5ab78a3973fc74e9a31a48de313d57ce7a631ef67d7621","parent":"294a7ab0a962998011c62781fe2262db352693497104b7fa0f036c208d41e681","source":"0001493152-26-010282","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":357,"hourly_limit":500,"remaining":143,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}